2021-11-14-世界卫生组织-Global_Technical_Meeting_on_MERS-CoV_and_Other_Emerging_Zoonotic_Coronaviruses_-_agenda_7页_1mb

报告摘要

Summary of the Global Technical Meeting on MERS-CoV and Other Emerging Zoonotic Coronaviruses (15-16 November 2021)

Core Content

The 2021 Global Technical Meeting on MERS-CoV and Other Emerging Zoonotic Coronaviruses was held virtually and aimed to review the latest scientific findings, enhance global collaboration, and improve preparedness for MERS-CoV and other zoonotic coronaviruses in the context of the ongoing COVID-19 pandemic. The meeting emphasized the importance of a One Health approach, integrating efforts between animal health, public health, and environmental sectors.

Main Objectives

The meeting had the following specific objectives:

To summarize the latest scientific findings and country experiences on MERS-CoV since the last global technical meeting in September 2017.
To facilitate coordination and communication between animal health, public health, and environmental sectors in outbreak preparedness, surveillance, and prevention.
To highlight how MERS-CoV research has contributed to the global effort against SARS-CoV-2.
To apply lessons learned from the COVID-19 pandemic to MERS-CoV and other emerging zoonotic coronaviruses.
To summarize priority actions and research for the continued control and prevention of MERS-CoV.

Key Outcomes

The expected outcomes of the meeting included:

A reinforced global commitment to maintain vigilance for MERS-CoV and other emerging zoonotic coronaviruses.
An updated public health research agenda for MERS-CoV, with newly prioritized research questions.

Key Topics and Speakers

Day 1: 15 November 2021

Welcome and Opening Remarks:
- Keith Sumption (FAO), Michael Ryan (WHO), Montserrat Arroyo (OIE), Haleema Al Serehi (KSA)
Plenary Session 1: How MERS-CoV supported the COVID-19 response
- Global Preparedness for MERS-CoV and the COVID-19 Response: Maria Van Kerkhove (WHO)
- MERS-CoV and COVID-19 vaccine development: Sarah Gilbert (University of Oxford, UK)
- Panel discussion: Sarah Gilbert, Maria Van Kerkhove, Sophie von Dobschuetz (FAO)
- Facilitator: Shagun Khare (WHO)
- EMRO regional MERS meeting summary: Abdinasir Abubakar (EMRO)
Plenary Session 2: Assessing the risks of MERS-CoV and other CoVs
- Update on MERS-CoV in animals: Emma Gardner (FAO), Gounalan Pavade (OIE)
- MERS-CoV Risk at the Animal-Human Interface: Malik Peiris (HKU, HK SAR)
- Overview of CoVs in animals: Alessio Lorusso (IZSAM, Italy)
- Assessing the risk of nosocomial outbreaks: Muhammad A. Halwani (Al Baha University, KSA)
Parallel Session 1: Surveillance challenges
- Sustainable surveillance in animal populations: Ibrahim Ahmad Qasim (KSA)
- Human surveillance at mass gatherings: Anas Abdulhafeez Khan (KSA)
- Integrating MERS-CoV, SARS-CoV and nCoV into respiratory disease surveillance: Stefano Tempia (EMRO)
- OH outbreak investigation milestones and metrics: Mark Smolinski (Ending Pandemics)
Parallel Session 2: Addressing nosocomial outbreaks
- Risk factors for superspreading events: Jaffar Al Tawfiq (KSA)
- IPC for respiratory pathogens: Majed Alshomrani (KSA)
- Improvements in IPC following nosocomial outbreaks: Tong Ryong Jung (ROK)
- Environmental persistence of MERS-CoV: Neeltje van Doremalen (NIH, USA)

Day 2: 16 November 2021

Welcome and Day 1 summary:
- Sophie von Dobschuetz (FAO)
Overview from parallel sessions 1 and 2:
- Ryan Aguanno (FAO), Abdullah Algwizani (KSA Public Health Authority)
Plenary Session 3: How has COVID-19 shifted our thinking?
- Panel discussion: Marion Koopmans (Erasmus, The Netherlands), Supaporn Wacharapluesadee (Thailand), Christian Drosten (Germany), Stefan Weber (UAE), Ahmad Albarag (KSA), Eun-Jin Kim (ROK)
- Facilitator: Amal Barakat (EMRO)
Parallel Session 3: Communities and communications
- Panel discussion: Roba B. Jilo (Tufts University, USA), Bhanu Chaudhary (UAE University), Mindy Frost (WHO), Rachel James (RCCE, Eastern and Southern Africa), Mohamed Nour (Qatar)
Parallel Session 4: Advancing Research and Development
- Overview of R&D agenda: Bart Haagmans (Erasmus, The Netherlands)
- Where are we with therapeutics for MERS-CoV?: Yaseen Arabi (KAIMRC, KSA)
- How has SARS-CoV-2 work advanced progress for MERS-CoV?: Yaseen Arabi
- Update on MERS-CoV vaccination for dromedary camels: Naif Alharbi (KAIMRC, KSA)
- Coronavirus Research and Innovation Network: Julian Hiscox (University of Liverpool, UK)
Meeting Closure
- Overview from parallel sessions 1 and 2: Ahmed El Idrissi (FAO), Hanan Balkhy (WHO)
- Meeting summary and identification of next steps: Maria Van Kerkhove (WHO), Sophie von Dobschuetz (FAO), Gounalan Pavade (OIE)

Participants

Participants included:

Representatives from Ministries of Health and Agriculture in affected and at-risk countries.
MERS-CoV and zoonotic CoV subject matter experts and researchers.
Funding agencies, industrial partners.
Representatives from FAO, OIE, and WHO at headquarters, regional, and national levels.